New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
07:55 EDTCBST, CBST, DRTX, DRTXFDA Anti-Infective Drugs Advisory Committee to hold a meeting
The Committee discusses Cubist Pharmaceuticals (CBST), (formerly Trius Therapeutics' (TSRX) new drug applications (NDAs) 205-435 and 205-436 for tedizolid phosphate tablets and tedizolid phosphate injection, respectively. Also to be discussed will be Durata Therapeutics International's (DRTX) NDA 021-883, dalbavancin hydrochloride for intravenous injection at the meeting being held at FDA Silver Spring, Maryland offices on March 31 at 8 am. []:[https://collaboration.fda.gov/aidac33114/]
News For CBST;DRTX From The Last 14 Days
Check below for free stories on CBST;DRTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 22, 2014
07:31 EDTCBSTCubist annouces EMA acceptance of ceftolozane, tazobactam MAA
Cubist announced that the European Medicines Agency has accepted for review the company’s Marketing Authorization Application for its investigational antibiotic ceftolozane, tazobactam. Cubist is seeking approval of ceftolozane/tazobactam for the treatment of complicated urinary tract Infections and complicated intra-abdominal infections, with a decision from the European Commission expected during 1H15. The MAA submission is based on positive data from two pivotal Phase 3 clinical trials of ceftolozane, tazobactam in complicated urinary tract infections and complicated intra-abdominal infections. These studies met both the EMA and U.S. Food and Drug Administration specified primary endpoints. Results of the secondary analyses were consistent with and supportive of the primary outcomes.
August 18, 2014
11:41 EDTCBSTCubist rises after report sparks takeover interest speculation
Subscribe for More Information
09:43 EDTCBSTCubist may receive takeover interest, Bloomberg reports
Cubist Pharmaceuticals' (CBST) focus on bacterial infections could attract takeover interest, Bloomberg reports in its Real M&A column. Reference Link
August 11, 2014
15:27 EDTDRTXWedbush to hold a conference
Life Sciences Management Conference to be held in New York on August 12-13.
August 8, 2014
17:49 EDTCBSTCubist issues voluntary nationwide recall of nine lots of CUBICIN
Subscribe for More Information
10:16 EDTDRTXHigh option volume stocks
High option volume stocks: TKMR JOE HMSY TDC XOMA XPO VGK DKS BCOR DRTX
09:06 EDTDRTXDurata could be cash flow positive by late 2016, says Janney Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use